According to Sage Therapeutics 's latest financial reports and stock price the company's current number of shares outstanding is 60,136,198. At the end of 2024 the company had 60,136,198 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2024 | 60.13 M | 0.37% |
2023 | 59.91 M | 0.7% |
2022 | 59.49 M | 1.01% |
2021 | 58.89 M | 13.01% |
2020 | 52.11 M | 0.54% |
2019 | 51.83 M | 10.58% |
2018 | 46.87 M | 18.43% |
2017 | 39.58 M | 6.41% |
2016 | 37.19 M | 29.11% |
2015 | 28.81 M | 47.13% |
2014 | 19.58 M | 16.74% |
2013 | 16.77 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Regulus Therapeutics RGLS | 19,628,815 | -67.36% | ๐บ๐ธ USA |
Intercept Pharmaceuticals
ICPT | 41,792,000 | -30.50% | ๐บ๐ธ USA |
Horizon Therapeutics
HZNP | 228,743,143 | 280.38% | ๐ฎ๐ช Ireland |
Eagle Pharmaceuticals
EGRX | 13,090,852 | -78.23% | ๐บ๐ธ USA |